EGFR and neoplasm: Prior comparisons across tumor cell lines have of course demonstrated relationships between cell behaviors and the levels of key proteins in the mechanism of interest; for example, the level of epidermal growth factor receptor (EGFR) ligands predicted sensitivity to anti-EGFR therapies,32 and receptor levels predicted sensitivity to macrophage-secreted factors.33